




Searching News Database: Osteoarthritis
HSMN NewsFeed - 14 May 2024
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
HSMN NewsFeed - 4 Oct 2023
U.S. FDA Grants Lipogems(R) Second IDE Approval for a Clinical Trial on the Treatment for Knee OA
U.S. FDA Grants Lipogems(R) Second IDE Approval for a Clinical Trial on the Treatment for Knee OA
HSMN NewsFeed - 11 Apr 2022
CMS grants outpatient facility code for insertion of Stryker's InSpace subacromial balloon spacer
CMS grants outpatient facility code for insertion of Stryker's InSpace subacromial balloon spacer
HSMN NewsFeed - 30 Mar 2022
FDA approves CartiHeal's Implant for the Treatment of Cartilage and Osteochondral Defects
FDA approves CartiHeal's Implant for the Treatment of Cartilage and Osteochondral Defects
HSMN NewsFeed - 4 Jun 2021
Ortho Regenerative Technologies Receives Clinical Hold Letter From the U.S. FDA
Ortho Regenerative Technologies Receives Clinical Hold Letter From the U.S. FDA
HSMN NewsFeed - 28 Apr 2021
Roam Robotics Announces Ascend Smart Knee, Pioneering a New Era of Human Mobility
Roam Robotics Announces Ascend Smart Knee, Pioneering a New Era of Human Mobility
HSMN NewsFeed - 16 Feb 2021
Akan Biosciences Announces FDA Acceptance of IND Application for StroMel(TM) in Osteoarthritis of Knee
Akan Biosciences Announces FDA Acceptance of IND Application for StroMel(TM) in Osteoarthritis of Knee
HSMN NewsFeed - 5 Jan 2021
Ortho Regenerative Technologies Enters Into Global License With Hanuman Pelican, Inc.
Ortho Regenerative Technologies Enters Into Global License With Hanuman Pelican, Inc.
HSMN NewsFeed - 19 Oct 2020
Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners
Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners
HSMN NewsFeed - 12 Oct 2020
CartiHeal Receives FDA "Breakthrough Device Designation" for the novel Agili-C Implant
CartiHeal Receives FDA "Breakthrough Device Designation" for the novel Agili-C Implant
HSMN NewsFeed - 2 Sep 2020
Smith & Nephew launches NOVOSTITCH(TM) PRO Meniscal Repair System in Europe
Smith & Nephew launches NOVOSTITCH(TM) PRO Meniscal Repair System in Europe
HSMN NewsFeed - 24 Jul 2020
Bimekizumab Superior to Cosentyx(R) in Achieving Complete Psoriasis Skin Clearance
Bimekizumab Superior to Cosentyx(R) in Achieving Complete Psoriasis Skin Clearance
HSMN NewsFeed - 5 Jun 2019
FDA Premarket Approval Granted for DT MedTech's Hintermann Series H3(TM) Total Ankle Replacement System
FDA Premarket Approval Granted for DT MedTech's Hintermann Series H3(TM) Total Ankle Replacement System
HSMN NewsFeed - 29 Apr 2019
First Patient in New England Treated With the Agili-C(TM) Implant at CartiHeal's Pivotal Study
First Patient in New England Treated With the Agili-C(TM) Implant at CartiHeal's Pivotal Study
HSMN NewsFeed - 28 Mar 2019
Hyalex Orthopaedics, synthetic cartilage company, adds new funding; expanding Series A total to $33MM
Hyalex Orthopaedics, synthetic cartilage company, adds new funding; expanding Series A total to $33MM
HSMN NewsFeed - 19 Feb 2019
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
HSMN NewsFeed - 15 Oct 2018
Medivir to Focus on its Clinical Development and Appoints Uli Hacksell as Acting CEO
Medivir to Focus on its Clinical Development and Appoints Uli Hacksell as Acting CEO
HSMN NewsFeed - 17 Sep 2018
CartiHeal Performs First Hungarian Case in the Agili-C(TM) Implant IDE Multinational Pivotal Study
CartiHeal Performs First Hungarian Case in the Agili-C(TM) Implant IDE Multinational Pivotal Study
HSMN NewsFeed - 14 May 2018
CurveBeam Announces FDA 510(k) Clearance for LineUP Weight Bearing Multi-Extremity CT System
CurveBeam Announces FDA 510(k) Clearance for LineUP Weight Bearing Multi-Extremity CT System
HSMN NewsFeed - 7 Feb 2018
UNITY Biotechnology Adds Accomplished R&D Leader David L. Lacey, M.D., to Board of Directors
UNITY Biotechnology Adds Accomplished R&D Leader David L. Lacey, M.D., to Board of Directors
HSMN NewsFeed - 22 Jan 2018
Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
HSMN NewsFeed - 5 Dec 2017
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
HSMN NewsFeed - 17 Nov 2017
MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document
MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document
HSMN NewsFeed - 10 Nov 2017
Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe
Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe
HSMN NewsFeed - 3 Nov 2017
Symic Bio Appoints Wayne Froland, Ph.D., as Executive Vice President of Technical Operations
Symic Bio Appoints Wayne Froland, Ph.D., as Executive Vice President of Technical Operations
HSMN NewsFeed - 3 Oct 2017
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
HSMN NewsFeed - 11 Jul 2017
MedShape Launches the DynaFrame CF Deployment System for TTC Fusion Surgery
MedShape Launches the DynaFrame CF Deployment System for TTC Fusion Surgery
HSMN NewsFeed - 31 May 2017
Hyalex Orthopaedics Raises $16 Million Series A Financing and Appoints Chief Executive Officer
Hyalex Orthopaedics Raises $16 Million Series A Financing and Appoints Chief Executive Officer
HSMN NewsFeed - 15 May 2017
Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid(R) 2%
Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid(R) 2%
HSMN NewsFeed - 20 Apr 2017
FDA Clears Halyard Health's COOLIEF for the Management of Osteoarthritis Knee Pain
FDA Clears Halyard Health's COOLIEF for the Management of Osteoarthritis Knee Pain
HSMN NewsFeed - 7 Apr 2017
Flexion Therapeutics Announces Appointment of Yamo Deniz, MD, as Chief Medical Officer
Flexion Therapeutics Announces Appointment of Yamo Deniz, MD, as Chief Medical Officer
HSMN NewsFeed - 18 Jan 2017
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
HSMN NewsFeed - 29 Nov 2016
Moximed: First Patient Treated in US Study of Atlas(R) System for Unicompartmental Knee Osteoarthritis
Moximed: First Patient Treated in US Study of Atlas(R) System for Unicompartmental Knee Osteoarthritis
HSMN NewsFeed - 25 Jul 2016
MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo
MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo
HSMN NewsFeed - 25 May 2016
Ceterix Announces Appointment of Edward Graubart as Vice President, Sales
Ceterix Announces Appointment of Edward Graubart as Vice President, Sales
HSMN NewsFeed - 4 Apr 2016
Nuvo Pharmaceuticals(TM) Inc. Announces Appointment of Vice President, Business Development
Nuvo Pharmaceuticals(TM) Inc. Announces Appointment of Vice President, Business Development
HSMN NewsFeed - 16 Feb 2016
VIVLODEX(TM) Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain
VIVLODEX(TM) Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain
HSMN NewsFeed - 13 Jan 2016
Galapagos and Gilead Cleared by U.S. Federal Trade Commission to Close Global Partnership on Filgotinib
Galapagos and Gilead Cleared by U.S. Federal Trade Commission to Close Global Partnership on Filgotinib
HSMN NewsFeed - 18 Nov 2015
Moximed Announces CE Mark and First Commercial Use of Atlas(TM) Knee System
Moximed Announces CE Mark and First Commercial Use of Atlas(TM) Knee System
HSMN NewsFeed - 15 Jul 2015
Histogenics Corporation Announces Dr. Gloria Matthews as Chief Medical Officer
Histogenics Corporation Announces Dr. Gloria Matthews as Chief Medical Officer
HSMN NewsFeed - 15 Jun 2015
FH Ortho Receives FDA 510(k) Clearance for Its CALCAnail(R) Orthopedic Arthrodesis Nail
FH Ortho Receives FDA 510(k) Clearance for Its CALCAnail(R) Orthopedic Arthrodesis Nail
HSMN NewsFeed - 1 Jun 2015
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
HSMN NewsFeed - 13 Nov 2014
Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel
Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel
HSMN NewsFeed - 10 Sep 2014
Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
HSMN NewsFeed - 10 Jul 2014
Smith & Nephew enters commercial agreement to bring robotic navigation to the JOURNEY UNI Knee procedure
Smith & Nephew enters commercial agreement to bring robotic navigation to the JOURNEY UNI Knee procedure
HSMN NewsFeed - 3 Jun 2014
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
HSMN NewsFeed - 27 May 2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
HSMN NewsFeed - 19 May 2014
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
HSMN NewsFeed - 13 Mar 2014
Anika Therapeutics Announces Dismissal of MONOVISC(R) U.S. Patent Infringement Lawsuit
Anika Therapeutics Announces Dismissal of MONOVISC(R) U.S. Patent Infringement Lawsuit
HSMN NewsFeed - 23 Dec 2013
Blue Belt Technologies announces first Navio(TM) Unicondylar Knee Replacement performed in France
Blue Belt Technologies announces first Navio(TM) Unicondylar Knee Replacement performed in France
HSMN NewsFeed - 19 Nov 2013
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance
HSMN NewsFeed - 24 Oct 2013
Celsus Therapeutics Announces Appointment of Pablo Jimenez, M.D., to Chief Medical Officer
Celsus Therapeutics Announces Appointment of Pablo Jimenez, M.D., to Chief Medical Officer
HSMN NewsFeed - 8 Oct 2013
Moximed Initiates Study in UK of KineSpring(R) System in Patients with Knee Osteoarthritis
Moximed Initiates Study in UK of KineSpring(R) System in Patients with Knee Osteoarthritis
HSMN NewsFeed - 25 Sep 2013
Stryker Announces Definitive Agreement to Acquire MAKO Surgical Corp. for $1.65 Billion
Stryker Announces Definitive Agreement to Acquire MAKO Surgical Corp. for $1.65 Billion
HSMN NewsFeed - 22 Aug 2013
Horizon Pharma Announces Settlement of DUEXIS(R) Patent Litigation With Par Pharmaceutical
Horizon Pharma Announces Settlement of DUEXIS(R) Patent Litigation With Par Pharmaceutical
HSMN NewsFeed - 16 Jul 2013
Ceterix Announces U.S. Launch of Novel Device for Minimally Invasive Orthopaedic Procedures
Ceterix Announces U.S. Launch of Novel Device for Minimally Invasive Orthopaedic Procedures
HSMN NewsFeed - 5 Feb 2013
FDA Clears Sculptor Robotic Guidance Arm(TM) for Unicompartmental Knee Replacement Surgery
FDA Clears Sculptor Robotic Guidance Arm(TM) for Unicompartmental Knee Replacement Surgery
HSMN NewsFeed - 29 Jan 2013
Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
HSMN NewsFeed - 27 Nov 2012
Carbylan Biosurgery, Inc. and Shanghai Jingfeng Pharmaceutical Corporation Announce License Agreement
Carbylan Biosurgery, Inc. and Shanghai Jingfeng Pharmaceutical Corporation Announce License Agreement
HSMN NewsFeed - 1 Nov 2012
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
HSMN NewsFeed - 11 Oct 2012
Pfizer Announces Top-Line Results From A Phase 3 Long-Term Safety Study Of ALO-02:
Pfizer Announces Top-Line Results From A Phase 3 Long-Term Safety Study Of ALO-02:
HSMN NewsFeed - 7 May 2012
New Biologics Company, Bioventus, Launches with Focus on Active Orthopaedic Healing
New Biologics Company, Bioventus, Launches with Focus on Active Orthopaedic Healing
HSMN NewsFeed - 22 Mar 2012
Integra LifeSciences Launches New Shoulder Arthroplasty Device in Italy and Sweden
Integra LifeSciences Launches New Shoulder Arthroplasty Device in Italy and Sweden
HSMN NewsFeed - 30 Jan 2012
ConforMIS Reaches Funding Milestone with $89 Million in Series E Financing
ConforMIS Reaches Funding Milestone with $89 Million in Series E Financing
HSMN NewsFeed - 13 Sep 2011
Stellar Pharmaceuticals Receives European Approval for NeoVisc(R) Single Dose
Stellar Pharmaceuticals Receives European Approval for NeoVisc(R) Single Dose
HSMN NewsFeed - 20 Jul 2011
Carticept Medical(TM) Receives 510(k) Clearance for Navigator(TM) Delivery System
Carticept Medical(TM) Receives 510(k) Clearance for Navigator(TM) Delivery System
HSMN NewsFeed - 1 Jun 2011
ConforMIS Receives CE Mark Certification for iTotal(R) CR Patient-Specific Total Knee Resurfacing System
ConforMIS Receives CE Mark Certification for iTotal(R) CR Patient-Specific Total Knee Resurfacing System
HSMN NewsFeed - 19 Apr 2011
STAR Orthopaedics to Host Clinical Trial of FDA Approved Personalized Knee Implant
STAR Orthopaedics to Host Clinical Trial of FDA Approved Personalized Knee Implant
HSMN NewsFeed - 23 Mar 2011
Blue Cross and Blue Shield Companies to Reimburse SBi’s STAR(TM) Total Ankle Replacement
Blue Cross and Blue Shield Companies to Reimburse SBi’s STAR(TM) Total Ankle Replacement
HSMN NewsFeed - 3 Feb 2011
FDA Clears First Patient-Specific Implant System for Total Knee Replacement
FDA Clears First Patient-Specific Implant System for Total Knee Replacement
HSMN NewsFeed - 20 Jan 2011
Anika Therapeutics Appoints Industry Veteran Jeffery S. Thompson to Board of Directors
Anika Therapeutics Appoints Industry Veteran Jeffery S. Thompson to Board of Directors
HSMN NewsFeed - 6 Jan 2011
Stellar Pharmaceuticals Annouces the Approval of Uracyst(R) by the KFDA in South Korea
Stellar Pharmaceuticals Annouces the Approval of Uracyst(R) by the KFDA in South Korea
HSMN NewsFeed - 20 Dec 2010
VIVUS Files European Marketing Authorization Application for QNEXA(R) in the Treatment of Obesity
VIVUS Files European Marketing Authorization Application for QNEXA(R) in the Treatment of Obesity
HSMN NewsFeed - 15 Dec 2010
Pico-Tesla Starts Pilot Study of Magneceutical(R) Therapy For Fibromyalgia
Pico-Tesla Starts Pilot Study of Magneceutical(R) Therapy For Fibromyalgia
HSMN NewsFeed - 6 Dec 2010
Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
HSMN NewsFeed - 2 Nov 2010
Unigene Names Alex Martin VP Business Development and Head of Commercial Operations
Unigene Names Alex Martin VP Business Development and Head of Commercial Operations
HSMN NewsFeed - 7 Oct 2010
Integra LifeSciences Features the Integra(TM) Total Wrist Fusion System at the 65th Annual ASSH Meeting
Integra LifeSciences Features the Integra(TM) Total Wrist Fusion System at the 65th Annual ASSH Meeting
HSMN NewsFeed - 30 Jul 2010
Stellar Pharmaceuticals Inc. Signs Agreement for Distribution and Sale of Uracyst(R) in Spain
Stellar Pharmaceuticals Inc. Signs Agreement for Distribution and Sale of Uracyst(R) in Spain
HSMN NewsFeed - 23 Jul 2010
Emisphere Provides an Update on Osteoarthritis Phase III Study With Oral Calcitonin
Emisphere Provides an Update on Osteoarthritis Phase III Study With Oral Calcitonin
HSMN NewsFeed - 22 Jul 2010
FDA provides Complete Response Letter to NicOx's New Drug Application for naproxcinod
FDA provides Complete Response Letter to NicOx's New Drug Application for naproxcinod
HSMN NewsFeed - 22 Jun 2010
David Nichols Joins Knee Creations, LLC. as Senior VP of Product Development & Operations
David Nichols Joins Knee Creations, LLC. as Senior VP of Product Development & Operations
HSMN NewsFeed - 6 May 2010
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
HSMN NewsFeed - 5 May 2010
Stellar Pharmaceuticals Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Portugal
Stellar Pharmaceuticals Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Portugal
HSMN NewsFeed - 3 May 2010
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
HSMN NewsFeed - 9 Apr 2010
Stellar Pharmaceuticals Announces Steven H. Goldman Rejoins Board of Directors
Stellar Pharmaceuticals Announces Steven H. Goldman Rejoins Board of Directors
HSMN NewsFeed - 12 Mar 2010
Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer
Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer
HSMN NewsFeed - 3 Mar 2010
NicOx and Bausch & Lomb Announce Worldwide Licensing Agreement for NCX 116
NicOx and Bausch & Lomb Announce Worldwide Licensing Agreement for NCX 116
HSMN NewsFeed - 22 Feb 2010
Memometal Technologies Acquires OrthoGlide Ankle Technology From Advanced Bio-Surfaces, Inc.
Memometal Technologies Acquires OrthoGlide Ankle Technology From Advanced Bio-Surfaces, Inc.
HSMN NewsFeed - 4 Dec 2009
Orthofix International Introduces FUSION(R) Lateral OA Brace With New Low-Profile Hinge
Orthofix International Introduces FUSION(R) Lateral OA Brace With New Low-Profile Hinge
HSMN NewsFeed - 19 Nov 2009
Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"
Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"
HSMN NewsFeed - 14 Sep 2009
POZEN Names Elizabeth A. Cermak as Executive Vice President, Chief Commercial Officer
POZEN Names Elizabeth A. Cermak as Executive Vice President, Chief Commercial Officer
HSMN NewsFeed - 10 Jul 2009
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
HSMN NewsFeed - 23 Jun 2009
ConforMIS Receives CE Mark for the First and Only Personalized Bicompartmental Knee Resurfacing System
ConforMIS Receives CE Mark for the First and Only Personalized Bicompartmental Knee Resurfacing System
HSMN NewsFeed - 5 May 2009
Stellar Pharmaceuticals Inc. Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Italy
Stellar Pharmaceuticals Inc. Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Italy
HSMN NewsFeed - 7 Apr 2009
IntelGenx Corp. and Cary Pharmaceuticals File NDA for CPI-300 Antidepressant
IntelGenx Corp. and Cary Pharmaceuticals File NDA for CPI-300 Antidepressant
HSMN NewsFeed - 19 Mar 2009
Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals
Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals
HSMN NewsFeed - 12 Mar 2009
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
HSMN NewsFeed - 23 Feb 2009
Exactech Extends Knee Development License with Hospital for Special Surgery
Exactech Extends Knee Development License with Hospital for Special Surgery
HSMN NewsFeed - 17 Feb 2009
Cipher receives tentative FDA approval for extended-release tramadol capsules
Cipher receives tentative FDA approval for extended-release tramadol capsules
HSMN NewsFeed - 11 Feb 2009
JFK Memorial Hospital Announces Availability of Personalized Partial Knee Resurfacing System for Patients
JFK Memorial Hospital Announces Availability of Personalized Partial Knee Resurfacing System for Patients
HSMN NewsFeed - 29 Jan 2009
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
HSMN NewsFeed - 29 Jan 2009
POZEN Informed by FDA That Endoscopic Gastric Ulcer Incidence Continues to Be an Acceptable Primary Endpoint
POZEN Informed by FDA That Endoscopic Gastric Ulcer Incidence Continues to Be an Acceptable Primary Endpoint
HSMN NewsFeed - 5 Jan 2009
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
HSMN NewsFeed - 28 Nov 2008
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
HSMN NewsFeed - 26 Nov 2008
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
HSMN NewsFeed - 10 Sep 2008
Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
HSMN NewsFeed - 25 Aug 2008
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
HSMN NewsFeed - 8 Jul 2008
Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal Filler
Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal Filler
HSMN NewsFeed - 30 Jun 2008
Anika Therapeutics Announces Commercial Availability of MONOVISC(TM) in Europe
Anika Therapeutics Announces Commercial Availability of MONOVISC(TM) in Europe
HSMN NewsFeed - 13 Jun 2008
Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
HSMN NewsFeed - 13 Jun 2008
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
HSMN NewsFeed - 10 Jun 2008
Pain Therapeutics and King Pharmaceuticals Announce Submission of New Drug Application for Remoxy
Pain Therapeutics and King Pharmaceuticals Announce Submission of New Drug Application for Remoxy
HSMN NewsFeed - 3 Jun 2008
Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
HSMN NewsFeed - 29 Apr 2008
Medtronic and Scil Technology Establish Partnership for Dental Bone Regeneration Therapies
Medtronic and Scil Technology Establish Partnership for Dental Bone Regeneration Therapies
HSMN NewsFeed - 24 Apr 2008
Transdel Pharmaceuticals Appoints Chief Medical Officer and Chief Operating Officer
Transdel Pharmaceuticals Appoints Chief Medical Officer and Chief Operating Officer
HSMN NewsFeed - 25 Mar 2008
Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
HSMN NewsFeed - 24 Mar 2008
ConforMIS, Inc. Appoints Medical Device Veteran to Chief Operating Officer
ConforMIS, Inc. Appoints Medical Device Veteran to Chief Operating Officer
HSMN NewsFeed - 10 Mar 2008
Javelin Pharmaceuticals' Dyloject Accepted by Scottish Medicines Consortium (SMC)
Javelin Pharmaceuticals' Dyloject Accepted by Scottish Medicines Consortium (SMC)
HSMN NewsFeed - 29 Jan 2008
Anika Therapeutics Appoints Andrew J. Carter, Ph.D., as Chief Technology Officer
Anika Therapeutics Appoints Andrew J. Carter, Ph.D., as Chief Technology Officer
HSMN NewsFeed - 15 Jan 2008
POZEN Submits Human Lymphocyte Study for Treximet(TM) (Formerly Known as Trexima(TM))
POZEN Submits Human Lymphocyte Study for Treximet(TM) (Formerly Known as Trexima(TM))
HSMN NewsFeed - 13 Dec 2007
Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
HSMN NewsFeed - 7 Dec 2007
New Industry Data Demonstrates the Superiority of the BIRMINGHAM HIP(TM) Resurfacing System
New Industry Data Demonstrates the Superiority of the BIRMINGHAM HIP(TM) Resurfacing System
HSMN NewsFeed - 27 Nov 2007
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
HSMN NewsFeed - 20 Nov 2007
Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements
Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements
HSMN NewsFeed - 15 Nov 2007
Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement
Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement
HSMN NewsFeed - 12 Nov 2007
NicOx' naproxcinod phase 3 results presented at American College of Rheumatology
NicOx' naproxcinod phase 3 results presented at American College of Rheumatology
HSMN NewsFeed - 7 Nov 2007
New Clinical Study Shows Limbrel(TM) as Effective as Naproxen for Knee Osteoarthritis
New Clinical Study Shows Limbrel(TM) as Effective as Naproxen for Knee Osteoarthritis
HSMN NewsFeed - 6 Nov 2007
30-Year Johnson & Johnson Veteran Joins ConforMIS' Renowned Executive Team
30-Year Johnson & Johnson Veteran Joins ConforMIS' Renowned Executive Team
HSMN NewsFeed - 19 Oct 2007
Small Bone Innovations, Inc. Rolls out Next Generation RingFIX(TM) System and Introduces Forefoot Repair Set
Small Bone Innovations, Inc. Rolls out Next Generation RingFIX(TM) System and Introduces Forefoot Repair Set
HSMN NewsFeed - 12 Oct 2007
Alpharma Closes Transaction to License U.S. Rights for Prescription Topical NSAID Pain Drug
Alpharma Closes Transaction to License U.S. Rights for Prescription Topical NSAID Pain Drug
HSMN NewsFeed - 5 Oct 2007
POZEN Plans to Submit Response to Approvable Letter For Trexima(TM) Within the Next Ten Days
POZEN Plans to Submit Response to Approvable Letter For Trexima(TM) Within the Next Ten Days
HSMN NewsFeed - 25 Sep 2007
Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
HSMN NewsFeed - 18 Sep 2007
Anika Therapeutics Promotes Randall Wilhoite to Vice President-Operations
Anika Therapeutics Promotes Randall Wilhoite to Vice President-Operations
HSMN NewsFeed - 17 Sep 2007
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada
HSMN NewsFeed - 11 Sep 2007
Stellar Pharmaceuticals Agrees to Settle Dispute with European Uracyst Licensee
Stellar Pharmaceuticals Agrees to Settle Dispute with European Uracyst Licensee
HSMN NewsFeed - 17 Aug 2007
UCB Announces Submission of Lacosamide Marketing Application for Diabetic Neuropathic Pain
UCB Announces Submission of Lacosamide Marketing Application for Diabetic Neuropathic Pain
HSMN NewsFeed - 6 Aug 2007
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
HSMN NewsFeed - 2 Jul 2007
NicOx appoints Pascal Pfister MD as Chief Scientific Officer and strengthens R&D organization
NicOx appoints Pascal Pfister MD as Chief Scientific Officer and strengthens R&D organization
HSMN NewsFeed - 19 Jun 2007
Small Bone Innovations Adds Artelon(R) CMC Spacer Arthro to Thumb Osteo- Arthritis Implant Line
Small Bone Innovations Adds Artelon(R) CMC Spacer Arthro to Thumb Osteo- Arthritis Implant Line
HSMN NewsFeed - 13 Jun 2007
Logical Therapeutics Inc. Raises US $30M Series B to Advance Drug Pipeline Targeting Inflammatory Diseases
Logical Therapeutics Inc. Raises US $30M Series B to Advance Drug Pipeline Targeting Inflammatory Diseases
HSMN NewsFeed - 8 Jun 2007
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
HSMN NewsFeed - 6 Jun 2007
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
HSMN NewsFeed - 2 May 2007
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
HSMN NewsFeed - 30 Apr 2007
NicOx recruits Sanjiv Sharma as Vice President Commercial Affairs in the United States
NicOx recruits Sanjiv Sharma as Vice President Commercial Affairs in the United States
HSMN NewsFeed - 27 Apr 2007
Merck Receives Non Approvable Letter from FDA for ARCOXIA(R) (etoricoxib)
Merck Receives Non Approvable Letter from FDA for ARCOXIA(R) (etoricoxib)
HSMN NewsFeed - 25 Apr 2007
XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
HSMN NewsFeed - 18 Apr 2007
Iroko Pharmaceuticals Appoints John Vavricka as President and Chief Executive Officer
Iroko Pharmaceuticals Appoints John Vavricka as President and Chief Executive Officer
HSMN NewsFeed - 12 Apr 2007
FDA Advisory Committee Recommends Against Approval for Merck's NDA for ARCOXIA(R) (etoricoxib)
FDA Advisory Committee Recommends Against Approval for Merck's NDA for ARCOXIA(R) (etoricoxib)
HSMN NewsFeed - 26 Mar 2007
Iroko Pharmaceuticals Acquires Rights to Two Pharmaceutical Products from Merck & Co., Inc.
Iroko Pharmaceuticals Acquires Rights to Two Pharmaceutical Products from Merck & Co., Inc.
HSMN NewsFeed - 26 Mar 2007
Victory Pharma, Inc. Sales Force Expansion Signifies Growth of Its US Commercial Operations
Victory Pharma, Inc. Sales Force Expansion Signifies Growth of Its US Commercial Operations
HSMN NewsFeed - 19 Mar 2007
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
HSMN NewsFeed - 12 Mar 2007
Exactech, Inc. Cleared by FDA for U.S. Distribution of Equinoxe(R) Reverse Shoulder
Exactech, Inc. Cleared by FDA for U.S. Distribution of Equinoxe(R) Reverse Shoulder
HSMN NewsFeed - 7 Mar 2007
Nuvo announces further update on discussions with the FDA related to review of Pennsaid
Nuvo announces further update on discussions with the FDA related to review of Pennsaid
HSMN NewsFeed - 15 Feb 2007
Zimmer Holdings and ISTO Technologies Announce Start of Neocartilage Clinical Trial
Zimmer Holdings and ISTO Technologies Announce Start of Neocartilage Clinical Trial
HSMN NewsFeed - 12 Feb 2007
Advanced Bio-Surfaces Reports Over 125 Successful Implants of the OrthoGlide(TM) Medial Knee Implant
Advanced Bio-Surfaces Reports Over 125 Successful Implants of the OrthoGlide(TM) Medial Knee Implant
HSMN NewsFeed - 24 Jan 2007
Zylera Pharmaceuticals Announces Availability of RELAMINE for the Treatment of Osteoarthritis
Zylera Pharmaceuticals Announces Availability of RELAMINE for the Treatment of Osteoarthritis
HSMN NewsFeed - 8 Jan 2007
Horizon Therapeutics Announces Special Protocol Assessment With FDA for Phase 3 Trial Program
Horizon Therapeutics Announces Special Protocol Assessment With FDA for Phase 3 Trial Program
HSMN NewsFeed - 3 Jan 2007
Victory Pharma, Inc. Signs NAPRELAN(R) Agreement; US Field Sales Force to Expand
Victory Pharma, Inc. Signs NAPRELAN(R) Agreement; US Field Sales Force to Expand
HSMN NewsFeed - 3 Jan 2007
Hi-Tech Pharmacal Enters into Agreement with Victory Pharma, Inc. to Market and Distribute Naprelan(R)
Hi-Tech Pharmacal Enters into Agreement with Victory Pharma, Inc. to Market and Distribute Naprelan(R)
HSMN NewsFeed - 21 Dec 2006
Anika Therapeutics Receives FDA Approval for Its Cosmetic Tissue Augmentation Product
Anika Therapeutics Receives FDA Approval for Its Cosmetic Tissue Augmentation Product
HSMN NewsFeed - 13 Dec 2006
BioMimetic Therapeutics Announces Positive Results Using GEM OS1(TM) Bone Graft in Foot/Ankle Fusions
BioMimetic Therapeutics Announces Positive Results Using GEM OS1(TM) Bone Graft in Foot/Ankle Fusions
HSMN NewsFeed - 13 Nov 2006
Anika Therapeutics Appoints Constance Garrison as Vice President of Regulatory and Clinical Affairs
Anika Therapeutics Appoints Constance Garrison as Vice President of Regulatory and Clinical Affairs
HSMN NewsFeed - 13 Nov 2006
Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
HSMN NewsFeed - 10 Nov 2006
Merck Responds to FDA-Issued Approvable Letters for Arcoxia(R) (etoricoxib)
Merck Responds to FDA-Issued Approvable Letters for Arcoxia(R) (etoricoxib)
HSMN NewsFeed - 10 Nov 2006
NicOx receives FDA feedback that no cardiovascular outcomes study required for naproxcinod NDA
NicOx receives FDA feedback that no cardiovascular outcomes study required for naproxcinod NDA
HSMN NewsFeed - 27 Oct 2006
NicOx Naproxcinod Phase 3 OA Trial Meets Primary Endpoints and Shows Encouraging Blood Pressure Profile
NicOx Naproxcinod Phase 3 OA Trial Meets Primary Endpoints and Shows Encouraging Blood Pressure Profile
HSMN NewsFeed - 11 Oct 2006
Osta Announces Promising Clinical Results on Blood Tests for Parkinson's Disease & Alzheimer's Disease
Osta Announces Promising Clinical Results on Blood Tests for Parkinson's Disease & Alzheimer's Disease
HSMN NewsFeed - 2 Oct 2006
Genzyme Receives European Approval for Synvisc(R) In Ankle and Shoulder Osteoarthritis Indications
Genzyme Receives European Approval for Synvisc(R) In Ankle and Shoulder Osteoarthritis Indications
HSMN NewsFeed - 28 Sep 2006
Cerimon Pharmaceuticals Names Timothy J. McBride as Senior Vice President of Business Development
Cerimon Pharmaceuticals Names Timothy J. McBride as Senior Vice President of Business Development
HSMN NewsFeed - 27 Sep 2006
FDA Approves Clinical Trial For Medtronic's DIAM Spinal Stabilization System
FDA Approves Clinical Trial For Medtronic's DIAM Spinal Stabilization System
HSMN NewsFeed - 14 Sep 2006
Zimmer Holdings to Launch Innovative Locking Plate System at Orthopaedic Trauma Association Meeting
Zimmer Holdings to Launch Innovative Locking Plate System at Orthopaedic Trauma Association Meeting
HSMN NewsFeed - 12 Sep 2006
Arena Pharmaceuticals Initiates Lorcaserin Phase 3 Obesity Clinical Trial
Arena Pharmaceuticals Initiates Lorcaserin Phase 3 Obesity Clinical Trial
HSMN NewsFeed - 12 Sep 2006
Q-Med: Q-Med's First Product in the Field of Body Augmentations, MACROLANE, Approved in Europe
Q-Med: Q-Med's First Product in the Field of Body Augmentations, MACROLANE, Approved in Europe
HSMN NewsFeed - 7 Sep 2006
King Pharmaceuticals Announces Strategic Acquisition of Avinza(R) from Ligand Pharmaceuticals
King Pharmaceuticals Announces Strategic Acquisition of Avinza(R) from Ligand Pharmaceuticals
HSMN NewsFeed - 19 Jul 2006
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Mobic(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Mobic(R)
HSMN NewsFeed - 28 Jun 2006
Smith & Nephew and Q-MED Enter Into Strategic Alliance in Osteoarthritis Treatment
Smith & Nephew and Q-MED Enter Into Strategic Alliance in Osteoarthritis Treatment
HSMN NewsFeed - 30 May 2006
New Jersey Hospital Introduces Unique Alternative to Total Hip Replacement
New Jersey Hospital Introduces Unique Alternative to Total Hip Replacement
HSMN NewsFeed - 25 May 2006
Advanced Bio-Surfaces(R) Announces Initial Experiences of OrthoGlide(TM) Medial Knee Implant
Advanced Bio-Surfaces(R) Announces Initial Experiences of OrthoGlide(TM) Medial Knee Implant
HSMN NewsFeed - 19 May 2006
Nexa Orthopedics Receives FDA Clearance to Market Pyrolytic Carbon Implant
Nexa Orthopedics Receives FDA Clearance to Market Pyrolytic Carbon Implant
HSMN NewsFeed - 10 May 2006
Smith & Nephew Receives FDA Approval for BIRMINGHAM HIP(TM) Resurfacing System
Smith & Nephew Receives FDA Approval for BIRMINGHAM HIP(TM) Resurfacing System
Additional items found! 294

Members Archive contains
294 additional stories matching:
Osteoarthritis
(Password required)
Osteoarthritis
(Password required)